Company intelligence / Profile preview
Xiangxue Pharmaceutical
Guangzhou, Guangdong, Chinaxphcn.com ↗
- Ownership
- Private
- Employees
- ~2700
- Development stage
- Phase 2
01
Overview
Xiangxue Pharmaceutical has a broad portfolio including traditional Chinese medicines and modern biopharmaceuticals. Its pipeline includes small molecules and advanced cell therapies, with the most advanced programs in Phase 2 clinical trials targeting solid tumors. The company also produces over-the-counter antivirotic oral liquids and health supplements.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeTCR-T cell therapyT lymphocyte cell therapyChinese herbal compound medicineBiologic
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Athenex, Inc. – licensing agreement for oral paclitaxel, oral irinotecan, tirbanibulin ointment for China/Hong Kong/Macao marketsAxis Therapeutics Limited – collaboration on cellular immunotherapy research/programs
Beyond the preview
Go deeper on Xiangxue Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiangxue Pharmaceutical.